Page last updated: 2024-10-16

betaine and Dyslipidemias

betaine has been researched along with Dyslipidemias in 3 studies

glycine betaine : The amino acid betaine derived from glycine.

Dyslipidemias: Abnormalities in the serum levels of LIPIDS, including overproduction or deficiency. Abnormal serum lipid profiles may include high total CHOLESTEROL, high TRIGLYCERIDES, low HIGH DENSITY LIPOPROTEIN CHOLESTEROL, and elevated LOW DENSITY LIPOPROTEIN CHOLESTEROL.

Research Excerpts

ExcerptRelevanceReference
" In this study, we examined the influence of betaine on high-fructose-induced renal damage involving renal inflammation, insulin resistance and lipid accumulation in rats and explored its possible mechanisms."3.80Betaine supplementation protects against high-fructose-induced renal injury in rats. ( Fan, CY; Ge, CX; Kong, LD; Li, JM; Wang, MX; Wang, X, 2014)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's1 (33.33)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Zhang, T1
Lu, R1
Chen, Y1
Yuan, Y1
Song, S1
Yan, K1
Zha, Y1
Zhuang, W1
Cheng, Y1
Liang, J1
Fan, CY1
Wang, MX1
Ge, CX1
Wang, X1
Li, JM1
Kong, LD1
Davidson, MH1

Other Studies

3 other studies available for betaine and Dyslipidemias

ArticleYear
Hyperhomocysteinemia and dyslipidemia in point mutation G307S of cystathionine β-synthase-deficient rabbit generated using CRISPR/Cas9.
    Lipids in health and disease, 2020, Oct-14, Volume: 19, Issue:1

    Topics: Animals; Betaine; Body Weight; CRISPR-Cas Systems; Cystathionine beta-Synthase; Disease Models, Anim

2020
Betaine supplementation protects against high-fructose-induced renal injury in rats.
    The Journal of nutritional biochemistry, 2014, Volume: 25, Issue:3

    Topics: Animals; Betaine; Cytokines; Dietary Supplements; Dyslipidemias; Fructose; Hyperuricemia; Inflammati

2014
A clinical puzzle: fibrates and homocysteine elevation: editorial to: "fibrates may cause an abnormal urinary betaine loss which is associated with elevations in plasma homocysteine" by M. Lever et al.
    Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:5

    Topics: Animals; Betaine; Bezafibrate; Clofibric Acid; Dyslipidemias; Folic Acid; Homocysteine; Humans; Hypo

2009